Leo Nicolai and Rainer Kaiser Link Procoagulant Platelets and Thromboinflammation in CVD
Leo Nicolai, Physician-Researcher in Cardiology at Medizinische Klinik und Poliklinik I, LMU Klinikum München, shared on LinkedIn:
”Happy to share Rainer Kaiser‘s and my review about procoagulant platelets in cardiovascular disease just published in Nature Reviews Cardiology’‘
Platelets play a central role in haemostasis following vascular injury and are essential for thrombus formation.
Beyond aggregation and clot contraction, platelets can enter a distinct, highly activated procoagulant state that contributes to the development of cardiovascular diseases such as myocardial infarction, stroke, and deep vein thrombosis, and links thrombosis with inflammation.
This Review examines recent advances in understanding procoagulant platelets, including their role in macrovascular and microvascular clot formation and the key receptors and signalling pathways that define this activation state.
It also discusses the clinical relevance of procoagulant platelet activation and explores existing and emerging therapeutic strategies that may enable new diagnostic and treatment approaches for cardiovascular, inflammatory, and immune-mediated diseases.
Read the full article in Nature Reviews Cardiology.
Article: Procoagulant platelets: linking coagulation and thromboinflammation in cardiovascular disease
Authors: Rainer Kaiser, Leo Nicolai
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 3, 2026, 17:18Giacomo Rossi: Cysteine and Gut Health – MIT Finds the Switch
-
Jun 3, 2026, 17:00Amin Ullah: Presence of RBCs of Unequal Sizes in a Peripheral Blood Smear – Anisocytosis of RBC
-
Jun 3, 2026, 16:59Jean Connors: Discussing Cancer-Associated Thrombosis at the Japanese Society of Thrombosis and Hemostasis
-
Jun 3, 2026, 16:54Ayush Bhowmik: Failed Drug Became the World’s Most Widely Used Blood Thinner
-
Jun 3, 2026, 16:13Salvador Payán Pernía: Arguing against a Significant Role for Erythropoietin Analogues in the Management of PRCA
-
Jun 3, 2026, 16:08Pedro Henrique Las Casas: How Anticoagulant Agents and Quercetin Influence Cancer Cell Procoagulant Activity
-
Jun 3, 2026, 16:07Suraj Wilson: Back From ASCO 2026 With A Renewed Commitment To Cancer Research
-
Jun 3, 2026, 16:06Kerin A. Da Cruz: MSTU Team Is Creating The Future of Stroke Care In the Northeast Florida
-
Jun 3, 2026, 16:06Andrew Lee: Examining Rare Clotting Disorders After Adenovirus-Based COVID-19 Vaccination